Shimada T, Okuda Y
Osaka Prefectural Institute of Public Health, Japan.
Biochem Pharmacol. 1988 Feb 1;37(3):459-65. doi: 10.1016/0006-2952(88)90215-8.
The metabolic activation of procarcinogens and promutagens by human liver microsomal cytochrome P-450 has been investigated by means of a newly developed method measuring the induction of umu gene in Salmonella typhimurium TA1535/pSK1002 [T. Shimada and S. Nakamura, Biochem. Pharmac. 36, 1979 (1987)]. The chemicals examined were aflatoxin B1 (AFB1), eight carcinogenic heterocyclic aromatic amines isolated from protein and amino acid pyrolysates, and 2-aminoanthracene. Liver microsomes from six patients catalyzed the metabolic activation of these chemicals; 2-amino-3,5-dimethylimidazo[4,5-f]quinoline (MeIQ) and AFB1 were most actively bioactivated, followed by 2-amino-3-methylimidazo[4,5-f]quinoline (IQ), 2-aminoanthracene (2-AA) and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. At least two forms of human cytochrome P-450 may be involved in the activation of these procarcinogens. This suggestion was supported by the following lines of evidence: (a) addition of non-ionic detergent Emulgen 913 to the incubation mixture caused a more profound inhibition of microsome-catalyzed activation of AFB1 than of MeIQ, IQ and 2AA, (b) 7,8-benzoflavone stimulated the activation of AFB1 by about 2.5-fold, whereas it inhibited significantly the reactions with MeIQ, IQ and 2AA, and (c) polyclonal antibodies against a 3-methylcholanthrene-inducible form of rat cytochrome P-450 (P-450d) caused a marked inhibition of the metabolic activation of MeIQ, IQ and 2-AA by human liver microsomes though they did not show any effects on the microsomal activation of AFB1. Data are also presented showing that none of the reactions catalyzed by human liver microsomes were inhibited by antibodies to a phenobarbital-inducible form of rat cytochrome P-450 (P-450b). These results suggest that the human cytochrome P-450 isozyme that is immunochemically similar and, thus, homologous to rat P-450d plays a major role in the metabolic activation of several procarcinogens examined, and that the activation of AFB1 is catalyzed by another and, possibly, not phenobarbital-inducible form(s) of human cytochrome P-450.
通过一种新开发的测量鼠伤寒沙门氏菌TA1535/pSK1002中umu基因诱导的方法,对人肝微粒体细胞色素P - 450对前致癌物和前诱变剂的代谢激活作用进行了研究[T. Shimada和S. Nakamura,Biochem. Pharmac. 36, 1979 (1987)]。所检测的化学物质有黄曲霉毒素B1(AFB1)、从蛋白质和氨基酸热解产物中分离出的8种致癌杂环芳香胺以及2 - 氨基蒽。6名患者的肝微粒体催化了这些化学物质的代谢激活;2 - 氨基 - 3,5 - 二甲基咪唑并[4,5 - f]喹啉(MeIQ)和AFB1的生物激活最为活跃,其次是2 - 氨基 - 3 - 甲基咪唑并[4,5 - f]喹啉(IQ)、2 - 氨基蒽(2 - AA)和2 - 氨基 - 3,8 - 二甲基咪唑并[4,5 - f]喹喔啉。至少两种人细胞色素P - 450形式可能参与了这些前致癌物的激活。以下几方面证据支持了这一观点:(a)向孵育混合物中添加非离子去污剂乳化剂913对微粒体催化的AFB1激活的抑制作用比对MeIQ、IQ和2AA的抑制作用更显著,(b)7,8 - 苯并黄酮使AFB1的激活增加约2.5倍,而它显著抑制与MeIQ、IQ和2AA的反应,(c)针对大鼠细胞色素P - 450的3 - 甲基胆蒽诱导形式(P - 450d)的多克隆抗体对人肝微粒体对MeIQ、IQ和2 - AA的代谢激活有显著抑制作用,尽管它们对微粒体对AFB1的激活没有任何影响。还给出的数据表明,人肝微粒体催化的反应均未被针对大鼠细胞色素P - 450的苯巴比妥诱导形式(P - 450b)的抗体所抑制。这些结果表明,在免疫化学上与大鼠P - 450d相似且同源的人细胞色素P - 450同工酶在几种所检测的前致癌物的代谢激活中起主要作用,并且AFB1的激活是由人细胞色素P - 450的另一种可能非苯巴比妥诱导的形式催化的。